相关参考文献
注意:仅列出部分参考文献,下载原文获取全部文献信息。A Structure-based Design Approach for Generating High Affinity BRD4 D1-Selective Chemical Probes
Huarui Cui et al.
JOURNAL OF MEDICINAL CHEMISTRY (2022)
Identification of potent CypD inhibitors via pharmacophore based virtual screening, docking and molecular dynamics simulation
Xiao-Zhong Chen et al.
JOURNAL OF MOLECULAR STRUCTURE (2022)
Structural-based virtual screening and identification of novel potent antimicrobial compounds against YsxC of Staphylococcus aureus
Reena Kumari et al.
JOURNAL OF MOLECULAR STRUCTURE (2022)
Identification of novel dual inhibitors targeting XOR and URAT1 via multiple virtual screening methods
XinYing Zhu et al.
JOURNAL OF MOLECULAR STRUCTURE (2022)
In-silico studies for the development of novel RET inhibitors for cancer treatment
Sushanta Bhattacharya et al.
JOURNAL OF MOLECULAR STRUCTURE (2022)
Pharmacophore modeling, virtual screening, molecular docking and dynamics studies for the discovery of HER2-tyrosine kinase inhibitors: An in-silico approach
Gurubasavaraja Swamy Purwarga Matada et al.
JOURNAL OF MOLECULAR STRUCTURE (2022)
Discovery of novel 4-phenylquinazoline-based BRD4 inhibitors for cardiac fibrosis
Zhangxu He et al.
ACTA PHARMACEUTICA SINICA B (2022)
Discovery of selective HDAC/BRD4 dual inhibitors as epigenetic probes
Jingjing Chen et al.
EUROPEAN JOURNAL OF MEDICINAL CHEMISTRY (2021)
Identification of anti-mycobacterial agents against mmpL3: Virtual screening, ADMET analysis and MD simulations
Kaushikkumar A. Bhakhar et al.
JOURNAL OF MOLECULAR STRUCTURE (2021)
Semi-automated Optimization of the CHARMM36 Lipid Force Field to Include Explicit Treatment of Long-Range Dispersion
Yalun Yu et al.
JOURNAL OF CHEMICAL THEORY AND COMPUTATION (2021)
Novel brd4 inhibitors with a unique scaffold exhibit antitumor effects
Young Hun Kim et al.
ONCOLOGY LETTERS (2021)
Design, synthesis, and biological activity evaluation of a series of novel sulfonamide derivatives as BRD4 inhibitors against acute myeloid leukemia
Ziying Feng et al.
BIOORGANIC CHEMISTRY (2021)
Discovery and Preclinical Pharmacology of an Oral Bromodomain and Extra-Terminal (BET) Inhibitor Using Scaffold-Hopping and Structure-Guided Drug Design
Ashvinikumar Gavai et al.
JOURNAL OF MEDICINAL CHEMISTRY (2021)
In silico strategy for isoform-selective 5-HT2AR and 5-HT2CR inhibitors
Xiaohui Geng et al.
MOLECULAR SYSTEMS DESIGN & ENGINEERING (2021)
Cancer's epigenetic drugs: where are they in the cancer medicines?
Sorayya Ghasemi
PHARMACOGENOMICS JOURNAL (2020)
Design, synthesis, and biological evaluation of 4,5-dihydro-[1,2,4]triazolo[4,3-f]pteridine derivatives as novel dual-PLK1/BRD4 inhibitors
Ning-Yu Wang et al.
EUROPEAN JOURNAL OF MEDICINAL CHEMISTRY (2020)
Novel strategies targeting bromodomain-containing protein 4 (BRD4) for cancer drug discovery
Dailin Liang et al.
EUROPEAN JOURNAL OF MEDICINAL CHEMISTRY (2020)
Identification of xanthine oxidase inhibitors through hierarchical virtual screening
Ying Yang et al.
RSC ADVANCES (2020)
Identification of novel PPARα/γ dual agonists by pharmacophore screening, docking analysis, ADMET prediction and molecular dynamics simulations
Xiao-Yan Feng et al.
COMPUTATIONAL BIOLOGY AND CHEMISTRY (2019)
Design, Synthesis, and in vitro Biological Evaluation of 3,5-Dimethylisoxazole Derivatives as BRD4 Inhibitors
Xiangyang Li et al.
CHEMMEDCHEM (2018)
Design, synthesis and biological evaluation of benzo[cd]indo1-2(1H)-ones derivatives as BRD4 inhibitors
Yuxin Feng et al.
EUROPEAN JOURNAL OF MEDICINAL CHEMISTRY (2018)
DUB3 Promotes BET Inhibitor Resistance and Cancer Progression by Deubiquitinating BRD4
Xin Jin et al.
MOLECULAR CELL (2018)
Targeting Brd4 for cancer therapy: inhibitors and degraders
Yingchao Duan et al.
MEDCHEMCOMM (2018)
NF-κB signaling activation via increases in BRD2 and BRD4 confers resistance to the bromodomain inhibitor I-BET151 in U937 cells
Kotaro Hishiki et al.
LEUKEMIA RESEARCH (2018)
Bromodomain inhibitors and cancer therapy: From structures to applications
Montserrat Perez-Salvia et al.
EPIGENETICS (2017)
Molecular docking reveals the potential of phthalate esters to inhibit the enzymes of the glucocorticoid biosynthesis pathway
Shahzad Ahmad et al.
JOURNAL OF APPLIED TOXICOLOGY (2017)
Discovery of a series of dihydroquinoxalin-2(1H)-ones as selective BET inhibitors from a dual PLK1-BRD4 inhibitor
Jianping Hu et al.
EUROPEAN JOURNAL OF MEDICINAL CHEMISTRY (2017)
Drug Discovery Targeting Bromodomain-Containing Protein 4
Zhiqing Liu et al.
JOURNAL OF MEDICINAL CHEMISTRY (2017)
Discovery of N-(4-(2,4-Difluorophenoxy)-3-(6-methyl-7-oxo-6,7-dihydro-1H-pyrrolo[2,3-c]pyridin-4-yl)phenyl)ethanesulfonamide (ABBV-075/Mivebresib), a Potent and Orally Available Bromodomain and Extraterminal Domain (BET) Family Bromodomain Inhibitor
Keith F. McDaniel et al.
JOURNAL OF MEDICINAL CHEMISTRY (2017)
Identification of a Novel Class of BRD4 Inhibitors by Computational Screening and Binding Simulations
Bryce K. Allen et al.
ACS OMEGA (2017)
Discovery of novel BRD4 inhibitors by high-throughput screening, crystallography, and cell-based assays
Zhongya Sun et al.
BIOORGANIC & MEDICINAL CHEMISTRY LETTERS (2017)
Discovery of Benzotriazolo[4,3-d][1,4]diazepines as Orally Active Inhibitors of BET Bromodomains
Alexander M. Taylor et al.
ACS MEDICINAL CHEMISTRY LETTERS (2016)
An Overview on Small Molecule Inhibitors of BRD4
Wenhai Huang et al.
MINI-REVIEWS IN MEDICINAL CHEMISTRY (2016)
Transcriptional plasticity promotes primary and acquired resistance to BET inhibition
Philipp Rathert et al.
NATURE (2015)
Acetyl-lysine Binding Site of Bromodomain-Containing Protein 4 (BRD4) Interacts with Diverse Kinase Inhibitors
Stuart W. J. Ember et al.
ACS CHEMICAL BIOLOGY (2014)
g_mmpbsa-A GROMACS Tool for High-Throughput MM-PBSA Calculations
Rashmi Kumari et al.
JOURNAL OF CHEMICAL INFORMATION AND MODELING (2014)
The Mechanisms behind the Therapeutic Activity of BET Bromodomain Inhibition
Junwei Shi et al.
MOLECULAR CELL (2014)
PFI-1, a Highly Selective Protein Interaction Inhibitor, Targeting BET Bromodomains
Sarah Picaud et al.
CANCER RESEARCH (2013)
Discovery of Epigenetic Regulator I-BET762: Lead Optimization to Afford a Clinical Candidate Inhibitor of the BET Bromodomains
Olivier Mirguet et al.
JOURNAL OF MEDICINAL CHEMISTRY (2013)
Fragment-Based Drug Discovery of 2-Thiazolidinones as Inhibitors of the Histone Reader BRD4 Bromodomain
Lele Zhao et al.
JOURNAL OF MEDICINAL CHEMISTRY (2013)
Identification of a novel series of BET family bromodomain inhibitors: Binding mode and profile of I-BET151 (GSK1210151A)
Jonathan Seal et al.
BIOORGANIC & MEDICINAL CHEMISTRY LETTERS (2012)
Histone Recognition and Large-Scale Structural Analysis of the Human Bromodomain Family
Panagis Filippakopoulos et al.
CELL (2012)
Place your BETs: the therapeutic potential of bromodomains
R. K. Prinjha et al.
TRENDS IN PHARMACOLOGICAL SCIENCES (2012)
BET domain co-regulators in obesity, inflammation and cancer
Anna C. Belkina et al.
NATURE REVIEWS CANCER (2012)
Pol II waiting in the starting gates: Regulating the transition from transcription initiation into productive elongation
Sergei Nechaev et al.
BIOCHIMICA ET BIOPHYSICA ACTA-GENE REGULATORY MECHANISMS (2011)
Discovery and Characterizatlion of Small Molecule Inhibitors of the BET Family Bromodomains
Chun-wa Chung et al.
JOURNAL OF MEDICINAL CHEMISTRY (2011)
Generation and validation of the first predictive pharmacophore model for cyclin-dependent kinase 9 inhibitors
Cheng Fang et al.
JOURNAL OF MOLECULAR GRAPHICS & MODELLING (2011)
Inhibition of BET recruitment to chromatin as an effective treatment for MLL-fusion leukaemia
Mark A. Dawson et al.
NATURE (2011)
Bromodomain protein Brd3 associates with acetylated GATA1 to promote its chromatin occupancy at erythroid target genes
Janine M. Lamonica et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2011)
Selective inhibition of BET bromodomains
Panagis Filippakopoulos et al.
NATURE (2010)
3D-QSAR study of corticotropin-releasing factor 1 antagonists and pharmacophore-based drug design
Yingda Ye et al.
NEUROCHEMISTRY INTERNATIONAL (2010)
GROMACS 4: Algorithms for highly efficient, load-balanced, and scalable molecular simulation
Berk Hess et al.
JOURNAL OF CHEMICAL THEORY AND COMPUTATION (2008)
Brd2 is a TBP-associated protein and recruits TBP into E2F-1 transcriptional complex in response to serum stimulation
Jinhong Peng et al.
MOLECULAR AND CELLULAR BIOCHEMISTRY (2007)
Glide: A new approach for rapid, accurate docking and scoring. 2. Enrichment factors in database screening
TA Halgren et al.
JOURNAL OF MEDICINAL CHEMISTRY (2004)